Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

16 structures for Q09161

Entry ID Method Resolution Chain Position Source
1H2T X-ray 210 A PDB
1H2U X-ray 240 A PDB
1H2V X-ray 200 A C 20-790 PDB
1H6K X-ray 200 A A/B/C 20-790 PDB
1N52 X-ray 211 A A 1-790 PDB
1N54 X-ray 272 A A 1-790 PDB
3FEX X-ray 355 A A 1-790 PDB
3FEY X-ray 220 A A 1-790 PDB
5OO6 X-ray 280 A A/D/G/J/M/P/S/V 20-790 PDB
5OOB X-ray 279 A A/C/F/I 20-790 PDB
6D0Y X-ray 268 A C 24-790 PDB
7ABG EM 780 A A5 1-790 PDB
8BY6 EM 319 A A 20-790 PDB
8PMP EM 343 A A 20-790 PDB
8PNT EM 346 A A 20-790 PDB
AF-Q09161-F1 Predicted AlphaFoldDB

399 variants for Q09161

Variant ID(s) Position Change Description Diseaes Association Provenance
CA5147980
rs759611269
2 S>P No ClinGen
ExAC
gnomAD
rs752897059
CA5147982
4 R>W No ClinGen
ExAC
gnomAD
CA5147983
rs549300474
6 H>Y No ClinGen
1000Genomes
ExAC
gnomAD
CA374182422
rs1183515028
8 D>G No ClinGen
TOPMed
rs1221182942
CA374182418
8 D>Y No ClinGen
gnomAD
rs764204341
CA5148005
12 G>D No ClinGen
ExAC
gnomAD
rs902054154
CA196749129
15 P>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1188435196
CA374183833
15 P>S No ClinGen
TOPMed
rs1170652461
CA374183918
22 S>F No ClinGen
gnomAD
rs1254118270
CA374183912
22 S>T No ClinGen
TOPMed
CA374183939
rs1446941455
25 N>D No ClinGen
Ensembl
CA374183942
rs1184462536
25 N>S No ClinGen
TOPMed
rs757529989
CA5148007
26 E>D No ClinGen
ExAC
gnomAD
CA5148006
rs754155815
26 E>V No ClinGen
ExAC
gnomAD
rs111406212
CA196749142
29 D>G No ClinGen
Ensembl
TCGA novel 31 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5148008
rs765743935
38 V>L No ClinGen
ExAC
gnomAD
rs776693991
CA5148024
45 S>P No ClinGen
ExAC
gnomAD
CA374184227
rs1313574427
47 E>G No ClinGen
gnomAD
TCGA novel 61 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 62 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs199768033
CA374184426
62 P>L No ClinGen
1000Genomes
ExAC
gnomAD
rs199768033
CA5148028
62 P>R No ClinGen
1000Genomes
ExAC
gnomAD
rs750751156
CA5148027
62 P>S No ClinGen
ExAC
gnomAD
rs766979856
CA5148029
63 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs752179444
CA5148030
64 Y>F No ClinGen
ExAC
gnomAD
CA196749463
rs923722759
65 K>R No ClinGen
Ensembl
CA5148032
rs749990957
70 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs1013344069
CA196749479
74 T>A No ClinGen
TOPMed
gnomAD
CA374184583
rs1186113285
74 T>I No ClinGen
gnomAD
rs760042997
CA5148049
76 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs1016432056
CA196715084
77 R>C No ClinGen
TOPMed
rs368904475
CA5148050
77 R>H No ClinGen
ESP
ExAC
gnomAD
rs1297754470
CA374164571
80 P>S No ClinGen
TOPMed
CA5148053
rs561132889
88 T>A No ClinGen
1000Genomes
ExAC
gnomAD
rs200044823
CA5148054
90 V>A No ClinGen
ExAC
gnomAD
CA374164748
rs1232001888
92 L>R No ClinGen
gnomAD
TCGA novel 94 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs757022224
CA5148055
97 N>S No ClinGen
ExAC
gnomAD
rs757022224
CA5148056
97 N>T No ClinGen
ExAC
gnomAD
CA5148057
rs375702222
99 N>S No ClinGen
ESP
ExAC
gnomAD
rs771979745
CA5148058
100 F>C No ClinGen
ExAC
TOPMed
gnomAD
rs1587997993
CA374164815
103 E>K No ClinGen
Ensembl
rs770066641
CA5148061
106 E>D No ClinGen
ExAC
gnomAD
rs78263197
CA5148060
106 E>K No ClinGen
ExAC
gnomAD
CA374164844
rs1564018751
107 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA374164859
rs1198382403
108 M>I No ClinGen
gnomAD
CA374164851
rs1450091347
108 M>V No ClinGen
gnomAD
rs773541128
CA5148062
110 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs763319595
CA5148063
110 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 111 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374165006
rs1419983512
120 N>D No ClinGen
TOPMed
CA5148065
rs201055450
121 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs960465959
CA196715197
123 E>A No ClinGen
TOPMed
gnomAD
TCGA novel 124 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1158887405
CA374165072
124 A>V No ClinGen
gnomAD
CA5148069
rs143745791
125 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1241100167
CA374165094
126 Y>C No ClinGen
TOPMed
CA5148082
rs749413155
129 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs771120940
CA5148083
129 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA196716399
rs1006182196
131 L>F No ClinGen
TOPMed
TCGA novel 131 L>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs113188050
CA196716400
132 S>P No ClinGen
Ensembl
rs1447096287
CA869004899
137 C>Y No ClinGen
TOPMed
CA196716410
rs143244138
138 H>R No ClinGen
ESP
rs1315415591
CA374165394
138 H>Y No ClinGen
gnomAD
TCGA novel 139 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374165437
rs1244513780
141 A>S No ClinGen
TOPMed
gnomAD
CA196716413
rs1047126908
COSM1103039
142 A>T Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs764615349
CA5148089
COSM403880
143 P>L lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA5148088
rs761121798
143 P>S No ClinGen
ExAC
gnomAD
rs761328077
CA5148091
145 M>I No ClinGen
ExAC
gnomAD
CA5148090
rs776051965
145 M>V No ClinGen
ExAC
gnomAD
CA374165490
rs1322644123
146 V>G No ClinGen
TOPMed
rs570584263
CA5148093
148 M>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs764931826
CA5148092
148 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1381870282
CA374165517
149 F>L No ClinGen
gnomAD
TCGA novel 152 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5148094
rs148430361
154 S>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA196716454
rs954834241
154 S>T No ClinGen
TOPMed
rs199742053
CA5148095
155 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 157 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1377606459
CA374165660
158 E>G No ClinGen
gnomAD
rs367832805
CA5148097
159 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1564019572
CA374165690
159 E>G No ClinGen
Ensembl
rs1379524559
CA374165722
160 D>V No ClinGen
gnomAD
CA5148100
rs749362324
162 P>L No ClinGen
ExAC
gnomAD
rs781283188
CA5148099
162 P>S No ClinGen
ExAC
gnomAD
CA374165771
rs1157885895
163 Q>L No ClinGen
gnomAD
rs766090854
CA5148116
165 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA5148117
rs751335902
166 R>Q No ClinGen
ExAC
gnomAD
rs1259880389
CA374166110
169 Y>F No ClinGen
gnomAD
CA5148118
rs754837272
170 V>L No ClinGen
ExAC
TOPMed
gnomAD
COSM199352
CA374166147
rs1247010633
171 Y>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA374166175
rs1564019760
173 F>L No ClinGen
Ensembl
rs752719793
CA5148120
174 L>R No ClinGen
ExAC
gnomAD
rs369507099
CA5148123
189 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA196716745
rs979828315
192 M>V No ClinGen
TOPMed
rs144152800
CA5148124
194 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs780266538
CA5148125
COSM307501
194 R>H kidney Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 197 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA196716760
rs1047607607
198 N>S No ClinGen
gnomAD
rs781641948
CA5148128
199 T>I No ClinGen
ExAC
gnomAD
CA5148129
rs748653256
201 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA5148130
rs770358840
204 K>R No ClinGen
ExAC
gnomAD
CA374168210
rs1430038305
205 R>S No ClinGen
TOPMed
CA374168225
rs1429967001
207 Q>E No ClinGen
gnomAD
rs1588001107
CA374168231
207 Q>R No ClinGen
Ensembl
rs924437552
CA196717770
208 K>N No ClinGen
Ensembl
rs755313839
CA196717778
210 H>N No ClinGen
ExAC
TOPMed
gnomAD
CA196717783
rs774893629
210 H>Q No ClinGen
Ensembl
CA5148149
rs755313839
210 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA5148150
rs781488285
211 V>G No ClinGen
ExAC
gnomAD
rs946708135
CA196717785
211 V>I No ClinGen
TOPMed
TCGA novel 212 P>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs943983017
CA196717792
212 P>S No ClinGen
Ensembl
CA5148151
rs748580819
213 M>V No ClinGen
ExAC
gnomAD
rs748737361
CA5148154
217 W>L No ClinGen
ExAC
gnomAD
CA5148155
rs146305083
219 A>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5148156
rs774123015
222 P>L No ClinGen
ExAC
gnomAD
rs774123015
CA196717809
222 P>R No ClinGen
ExAC
gnomAD
CA374168692
rs1200521524
232 L>V No ClinGen
gnomAD
rs1444644035
CA374168944
243 R>H No ClinGen
gnomAD
rs547285420
CA5148169
245 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
CA374169022
rs1242946926
246 E>D No ClinGen
TOPMed
gnomAD
TCGA novel 247 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA196717979
rs752763469
247 R>W No ClinGen
gnomAD
rs1454896839
CA374169156
253 Y>F No ClinGen
TOPMed
TCGA novel 253 Y>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374169213
rs1469739919
257 D>N No ClinGen
gnomAD
rs1445045378
CA374169241
258 S>G No ClinGen
Ensembl
rs1400817980
CA374169457
267 N>S No ClinGen
TOPMed
gnomAD
rs1403016979
CA374169510
270 P>S No ClinGen
gnomAD
CA5148175
rs757856712
272 T>S No ClinGen
ExAC
gnomAD
CA196718046
rs992187406
275 P>S No ClinGen
TOPMed
TCGA novel 280 S>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374169699
rs367848815
281 V>L No ClinGen
gnomAD
CA196718050
rs367848815
281 V>M No ClinGen
gnomAD
CA374169733
rs1276142130
283 P>T No ClinGen
gnomAD
CA5148176
rs377142866
284 M>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA374170010
rs1588001587
297 D>E No ClinGen
Ensembl
rs1363313647
CA374170781
312 F>C No ClinGen
gnomAD
rs746724831
CA5148198
312 F>L No ClinGen
ExAC
gnomAD
CA5148199
rs768217966
314 I>V No ClinGen
ExAC
gnomAD
rs776448255
CA5148200
315 E>D No ClinGen
ExAC
CA196719401
rs866735277
316 E>G No ClinGen
gnomAD
rs145175516
CA196719405
317 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
gnomAD
CA374170929
rs145175516
317 N>T No ClinGen
ESP
gnomAD
CA5148201
rs747943842
319 H>R No ClinGen
ExAC
gnomAD
CA374171008
rs1338363433
320 C>S No ClinGen
Ensembl
rs773042637
CA5148203
322 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs1587709986
CA374171096
324 S>C No ClinGen
Ensembl
CA5148204
rs762718765
325 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1267546890
CA374171143
326 W>C No ClinGen
gnomAD
rs767681467
CA5148205
327 K>E No ClinGen
ExAC
gnomAD
CA196719879
rs77021424
338 S>N No ClinGen
Ensembl
rs895821156
CA196719912
344 K>R No ClinGen
Ensembl
CA5148224
rs760681588
345 I>S No ClinGen
ExAC
gnomAD
rs1334655231
CA374172901
351 I>V No ClinGen
TOPMed
CA5148226
rs146487190
352 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1440314764
CA374173311
357 A>E No ClinGen
gnomAD
rs1297799166
CA374173348
361 Q>H No ClinGen
gnomAD
CA196721636
rs201033807
364 A>V No ClinGen
Ensembl
rs774789588
CA5148250
365 P>T No ClinGen
ExAC
gnomAD
TCGA novel 367 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs759059842
CA5148251
368 I>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 369 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 370 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 372 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5148253
rs752232675
374 T>A No ClinGen
ExAC
gnomAD
CA374173546
rs1564023347
376 L>F No ClinGen
Ensembl
CA374173571
rs1266547389
377 I>T No ClinGen
TOPMed
rs1564023359
CA374173598
379 L>Q No ClinGen
Ensembl
CA5148256
rs753651073
381 K>R No ClinGen
ExAC
gnomAD
rs1309666909
CA374173687
384 P>R No ClinGen
TOPMed
TCGA novel 385 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs940481465
CA196721681
386 S>C No ClinGen
Ensembl
rs1217182356
COSM3779464
CA374174008
392 A>V Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA5148272
rs201715578
400 M>L No ClinGen
1000Genomes
ExAC
gnomAD
rs763729923
CA5148273
401 R>G No ClinGen
ExAC
gnomAD
rs191669699
CA5148274
401 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA374174204
rs1365080891
402 L>S No ClinGen
gnomAD
rs1320278041
CA374174227
403 D>E No ClinGen
gnomAD
CA5148275
rs757052791
403 D>N No ClinGen
ExAC
gnomAD
rs377011060
CA5148276
404 T>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 405 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1429863415
CA374174324
408 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA374174341
rs1384657092
409 C>Y No ClinGen
gnomAD
CA374174551
rs1223757775
412 R>S No ClinGen
gnomAD
CA5148298
rs562093927
414 I>V No ClinGen
1000Genomes
ExAC
gnomAD
CA196722943
rs1010959075
418 S>F No ClinGen
Ensembl
TCGA novel 422 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 424 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA196722953
rs1043767378
427 R>C No ClinGen
Ensembl
CA5148300
rs529407443
427 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs1463500738
CA374175070
435 D>Y No ClinGen
TOPMed
rs751426033
CA5148322
436 C>F No ClinGen
ExAC
gnomAD
rs1463331210
CA374175263
440 D>E No ClinGen
gnomAD
CA5148323
rs759509804
440 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA196723213
rs1043584863
441 P>L No ClinGen
TOPMed
CA5148324
rs767499468
443 S>G No ClinGen
ExAC
gnomAD
rs1395347765
CA374175353
443 S>T No ClinGen
gnomAD
CA5148326
rs77602722
446 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs77602722
CA374175435
446 P>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs753846445
CA5148325
446 P>S No ClinGen
ExAC
gnomAD
rs946680169
CA196723230
448 F>L No ClinGen
Ensembl
CA374175531
rs1587715087
450 R>K No ClinGen
Ensembl
rs750692037
CA5148328
452 V>I No ClinGen
ExAC
gnomAD
rs1241402370
CA374175626
454 E>Q No ClinGen
TOPMed
CA5148329
rs758640371
456 C>F No ClinGen
ExAC
gnomAD
rs775535487
CA5148343
462 H>Y No ClinGen
ExAC
gnomAD
TCGA novel 463 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs761774774
CA5148344
463 Q>L No ClinGen
ExAC
TOPMed
gnomAD
rs761774774
CA374176378
463 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs929728395
CA196725491
464 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs765310353
CA5148345
COSM1103043
464 R>H Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs575725741
CA196725515
465 I>V No ClinGen
TOPMed
rs376131263
CA196725516
468 I>T No ClinGen
ESP
TOPMed
gnomAD
CA5148346
rs750531525
470 P>L No ClinGen
ExAC
gnomAD
CA374176479
rs1587718235
472 T>N No ClinGen
Ensembl
rs1461575346
CA374176536
477 C>R No ClinGen
gnomAD
CA374176565
rs1185118991
479 A>T No ClinGen
gnomAD
rs1382987877
CA374176586
480 N>S No ClinGen
gnomAD
CA5148348
rs543815167
482 T>A No ClinGen
1000Genomes
ExAC
gnomAD
rs1364986043
CA374176639
483 C>Y No ClinGen
gnomAD
CA5148352
rs565223329
488 G>A No ClinGen
1000Genomes
ExAC
gnomAD
CA374176758
rs1380865282
489 D>E No ClinGen
TOPMed
gnomAD
rs748815530
CA5148355
492 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA196725571
rs893749132
493 N>H No ClinGen
Ensembl
rs1261046976
CA374177665
493 N>K No ClinGen
gnomAD
CA5148372
rs767878003
494 S>F No ClinGen
ExAC
gnomAD
CA196729257
rs112377432
494 S>P No ClinGen
Ensembl
rs1457711237
CA374177698
495 L>F No ClinGen
TOPMed
TCGA novel 499 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs756581884
CA5148374
501 A>T No ClinGen
ExAC
gnomAD
CA5148375
rs778478202
502 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs1587720534
CA374177905
505 A>T No ClinGen
Ensembl
rs1420409527
CA374177943
507 A>G No ClinGen
TOPMed
CA374177975
rs1176131002
508 F>L No ClinGen
gnomAD
TCGA novel 508 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 510 S>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374178089
rs1380325163
514 N>S No ClinGen
TOPMed
CA5148376
rs753371425
515 D>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 515 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1437677053
CA374178161
519 S>G No ClinGen
TOPMed
rs1254673124
CA374178195
520 I>M No ClinGen
TOPMed
CA5148377
rs756898200
523 D>N No ClinGen
ExAC
gnomAD
CA374178281
rs1210269842
524 V>A No ClinGen
TOPMed
rs1432958061
CA374178263
524 V>I No ClinGen
gnomAD
rs1306811071
CA374178294
525 P>A No ClinGen
gnomAD
rs138518441
CA5148379
530 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs150516377
CA5148378
530 D>N No ClinGen
ESP
ExAC
CA374178600
rs368727721
533 D>H No ClinGen
ESP
ExAC
gnomAD
CA5148382
rs368727721
533 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA5148384
rs776589336
534 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA5148396
rs778501080
538 S>R No ClinGen
ExAC
gnomAD
CA374178992
rs1349230256
539 F>L No ClinGen
gnomAD
rs749934747
CA374179043
541 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs758020951
CA5148398
541 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA5148397
rs749934747
541 P>T No ClinGen
ExAC
TOPMed
gnomAD
CA196729831
rs1035915676
543 K>R No ClinGen
Ensembl
rs1315299106
CA374179102
544 I>M No ClinGen
gnomAD
CA5148400
rs141653335
544 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs978439391
CA196729834
544 I>V No ClinGen
TOPMed
rs1564027630
CA374179180
549 Q>H No ClinGen
Ensembl
CA374179207
rs1243162588
552 L>I No ClinGen
gnomAD
CA374179236
rs1451571445
553 H>Q No ClinGen
gnomAD
rs781092334
CA5148402
553 H>R No ClinGen
ExAC
gnomAD
rs769724189
CA374179308
557 K>I No ClinGen
ExAC
TOPMed
gnomAD
CA5148404
rs769724189
557 K>T No ClinGen
ExAC
TOPMed
gnomAD
rs1587721836
CA374179398
563 F>C No ClinGen
Ensembl
CA374179471
rs1243990501
567 A>V No ClinGen
TOPMed
gnomAD
CA5148428
rs745960045
569 F>L No ClinGen
ExAC
gnomAD
rs1333061085
CA374179646
571 E>G No ClinGen
gnomAD
rs772105621
CA5148429
572 V>I No ClinGen
ExAC
gnomAD
rs1405758678
CA374179693
574 K>R No ClinGen
TOPMed
CA374179717
rs1587722692
575 T>I No ClinGen
Ensembl
CA374179737
rs1349212050
577 A>S No ClinGen
gnomAD
rs900797208
CA196730537
579 S>N No ClinGen
Ensembl
CA5148431
rs576031865
579 S>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs769033892
CA5148432
580 D>G No ClinGen
ExAC
gnomAD
TCGA novel 584 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 586 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5148437
rs762511481
590 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA5148436
rs773658380
590 M>V No ClinGen
ExAC
gnomAD
TCGA novel 594 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374180101
rs1240332038
595 R>K No ClinGen
TOPMed
CA5148438
rs200307901
CA374180133
596 N>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA374180199
rs1463671483
599 Q>P No ClinGen
Ensembl
CA374181442
rs1455413094
600 M>I No ClinGen
TOPMed
rs1476216943
CA374181428
600 M>K No ClinGen
gnomAD
CA374181453
rs1166297551
601 I>T No ClinGen
gnomAD
rs1424724334
CA374181515
604 L>V No ClinGen
gnomAD
rs773638183
CA5148463
608 M>T No ClinGen
ExAC
gnomAD
CA5148464
rs763301023
609 I>V No ClinGen
ExAC
gnomAD
rs766937640
CA5148465
610 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs189780807
CA5148466
610 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA374181670
rs1295673921
613 I>T No ClinGen
gnomAD
rs759092106
CA5148467
614 V>I No ClinGen
ExAC
gnomAD
CA5148468
rs767122222
617 A>V No ClinGen
ExAC
gnomAD
TCGA novel 619 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760392584
CA5148470
621 N>S No ClinGen
ExAC
gnomAD
CA5148471
rs763732944
622 W>C No ClinGen
ExAC
TOPMed
gnomAD
CA5148474
rs199656608
630 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA196731882
rs76139042
630 R>H No ClinGen
ExAC
gnomAD
rs76139042
CA5148475
630 R>L No ClinGen
ExAC
gnomAD
rs1462896409
CA374181877
634 R>K No ClinGen
TOPMed
CA5148487
rs563025088
635 L>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1426352270
CA374181995
636 F>L No ClinGen
TOPMed
rs1459224114
CA374181990
636 F>Y No ClinGen
gnomAD
rs760207834
CA5148488
637 V>A No ClinGen
ExAC
gnomAD
CA374182006
rs1388333402
638 W>R No ClinGen
TOPMed
gnomAD
rs530473497
CA5148490
644 T>S No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 646 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA196733972
rs980313594
646 R>G No ClinGen
TOPMed
CA5148491
rs372649867
646 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1307706380
CA374182123
648 M>I No ClinGen
gnomAD
CA374182135
rs1352284898
649 N>S No ClinGen
gnomAD
CA374182159
rs1287548291
651 H>R No ClinGen
gnomAD
CA5148495
rs781352322
655 I>F No ClinGen
ExAC
gnomAD
rs35694910
CA5148497
657 K>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA374182244
rs1473885500
659 L>V No ClinGen
gnomAD
CA374182248
rs1180610932
660 E>K No ClinGen
gnomAD
rs1411773079
CA374182279
662 A>T No ClinGen
TOPMed
gnomAD
CA196733993
rs1048483539
665 K>R No ClinGen
TOPMed
rs1587726786
CA374182360
667 A>D No ClinGen
Ensembl
rs1564029976
CA374182355
667 A>P No ClinGen
Ensembl
rs1310351646
CA374182436
670 H>R No ClinGen
TOPMed
rs1178608336
CA374182499
672 R>Q No ClinGen
TOPMed
gnomAD
CA374182484
rs1480959894
672 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs563951596
CA5148518
673 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA374183111
rs546371242
678 D>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5148522
rs546371242
678 D>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5148524
rs746257224
680 S>G No ClinGen
ExAC
gnomAD
CA374183207
rs1245387917
686 G>E No ClinGen
gnomAD
rs372358511
CA196736167
687 V>F No ClinGen
ESP
TOPMed
gnomAD
rs372358511
CA374183213
687 V>I No ClinGen
ESP
TOPMed
gnomAD
rs746497048
CA196736186
689 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs375383269
CA196736177
689 E>K No ClinGen
ESP
CA5148529
rs564435323
692 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5148528
rs779166421
692 I>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 693 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374183294
rs1237723575
694 R>G No ClinGen
TOPMed
rs1213983150
CA374183298
694 R>P No ClinGen
TOPMed
rs1213983150
COSM172648
CA374183297
694 R>Q large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs369608673
CA5148531
698 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA196736229
rs373186546
698 K>T No ClinGen
ESP
TOPMed
TCGA novel 699 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1240128715
CA374183358
700 E>Q No ClinGen
TOPMed
rs773091094
CA5148532
701 S>Y No ClinGen
ExAC
gnomAD
rs267602330
CA196736233
709 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA374183483
rs267602330
709 L>I No ClinGen
gnomAD
rs1362619283
CA374183509
710 F>L No ClinGen
gnomAD
rs1322221272
CA374183502
710 F>Y No ClinGen
gnomAD
TCGA novel 712 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA374183524
COSM1464330
rs1315197808
712 V>I Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA374183542
rs1380665329
713 I>V No ClinGen
gnomAD
rs1426838162
CA374183701
716 R>W No ClinGen
gnomAD
rs765442451
CA374183762
720 I>F No ClinGen
ExAC
TOPMed
gnomAD
CA5148558
rs765442451
720 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs749349979
CA196736872
721 L>F No ClinGen
Ensembl
TCGA novel 726 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1310373726
CA374184380
726 V>I No ClinGen
gnomAD
CA374184383
rs1310373726
726 V>L No ClinGen
gnomAD
CA5148562
rs201932796
727 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA374184404
rs1275769807
727 R>P No ClinGen
TOPMed
gnomAD
CA374184402
rs1275769807
727 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA374184416
rs1347420902
728 C>R No ClinGen
TOPMed
gnomAD
TCGA novel 729 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1278052037
COSM1258794
CA374184430
729 E>K oesophagus [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1286426586
CA374184501
734 S>G No ClinGen
TOPMed
CA5148566
rs755750031
738 P>A No ClinGen
ExAC
gnomAD
CA374184565
rs1239779864
738 P>L No ClinGen
TOPMed
rs148698789
CA5148567
739 W>R No ClinGen
ESP
ExAC
gnomAD
TCGA novel 740 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5148568
rs748888761
741 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs1157431407
CA374184607
741 K>T No ClinGen
gnomAD
CA5148569
rs770525476
742 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs778725072
CA5148570
744 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1273533103
CA374184667
749 Q>H No ClinGen
TOPMed
TCGA novel 755 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA196738361
rs969569711
COSM1553885
760 Q>H lung [Cosmic] No ClinGen
cosmic curated
Ensembl
rs1370709913
CA374184758
760 Q>R No ClinGen
gnomAD
rs775998628
CA374184765
761 Y>C No ClinGen
ExAC
gnomAD
rs775998628
CA5148601
761 Y>F No ClinGen
ExAC
gnomAD
TCGA novel 762 M>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5148602
rs142212526
776 P>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA196738388
rs958280135
777 H>Q No ClinGen
TOPMed
rs1469769776
CA374184873
777 H>R No ClinGen
gnomAD
rs1459058704
CA374184882
778 I>T No ClinGen
gnomAD
CA5148603
rs377264051
781 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 782 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel
CA374184948
rs1314891821
785 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
gnomAD
CA374184959
rs1338650771
786 C>R No ClinGen
gnomAD
CA5148605
rs756788361
786 C>S No ClinGen
ExAC
gnomAD
rs764929932
CA5148606
789 Q>* No ClinGen
ExAC
gnomAD
rs764929932
CA374184992
789 Q>E No ClinGen
ExAC
gnomAD
rs749986117
CA5148607
790 A>G No ClinGen
ExAC
gnomAD
rs1279841584
CA374185006
790 A>S No ClinGen
TOPMed

No associated diseases with Q09161

3 regional properties for Q09161

Type Name Position InterPro Accession
domain MIF4G-like, type 3 28 - 240 IPR003890
domain MIF4G-like, type 1 326 - 470 IPR015172
domain MIF4G-like, type 2 485 - 759 IPR015174

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Localized in cytoplasmic mRNP granules containing untranslated mRNAs
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
mRNA cap binding complex Any protein complex that binds to an mRNA cap at any time in the lifetime of the mRNA.
nuclear cap binding complex A conserved heterodimeric protein complex that binds to the 5' terminal cap structure m7G(5')ppp(5')N of nascent eukaryotic RNA polymerase II transcripts such as pre-mRNA and U snRNA. The consists of proteins known as CBP20 and CBP80, binds to cap structures in the nucleus, and is involved in pre-mRNA splicing, 3'-end formation, and RNA nuclear export.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
ribonucleoprotein complex A macromolecular complex that contains both RNA and protein molecules.
RNA cap binding complex Any protein complex that binds to a specialized RNA cap structure at any time in the lifetime of the RNA.

5 GO annotations of molecular function

Name Definition
molecular adaptor activity The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
mRNA binding Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns.
RNA 7-methylguanosine cap binding Binding to a 7-methylguanosine group added cotranscriptionally to the 5' end of RNA molecules transcribed by polymerase II.
RNA binding Binding to an RNA molecule or a portion thereof.
RNA cap binding Binding to a 7-methylguanosine (m7G) group or derivative located at the 5' end of an RNA molecule.

25 GO annotations of biological process

Name Definition
7-methylguanosine mRNA capping Addition of the 7-methylguanosine cap to the 5' end of a nascent messenger RNA transcript.
alternative mRNA splicing, via spliceosome The process of generating multiple mRNA molecules from a given set of exons by differential use of exons from the primary transcript(s) to form multiple mature mRNAs that vary in their exon composition.
cap-dependent translational initiation The process where the cap structure, composed of a 7- methylguanosine (m7G) group and associated cap-binding proteins, located at the 5' end of an mRNA molecule, which serves as a molecular tag that marks the spot where the 40S ribosomal subunit, is recruited and will then scan in a 5' to 3' direction until an AUG codon is encountered in an appropriate sequence context to initiate mRNA translation.
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
histone mRNA metabolic process The chemical reactions and pathways involving an mRNA encoding a histone.
miRNA-mediated gene silencing A post-transcriptional gene silencing pathway in which regulatory microRNAs (miRNAs) elicit silencing of specific target genes. miRNAs are endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), miRNAs can downregulate gene expression by either of two posttranscriptional mechanisms: endonucleolytic cleavage of the RNA (often mRNA) or mRNA translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA. miRNAs are present in all the animals and in plants, whereas siRNAs are present in lower animals and in plants.
mRNA 3'-end processing Any process involved in forming the mature 3' end of an mRNA molecule.
mRNA export from nucleus The directed movement of mRNA from the nucleus to the cytoplasm.
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.
mRNA transcription by RNA polymerase II The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter.
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins.
positive regulation of cell growth Any process that activates or increases the frequency, rate, extent or direction of cell growth.
positive regulation of mRNA 3'-end processing Any process that activates or increases the frequency, rate or extent of mRNA 3'-end processing.
positive regulation of mRNA splicing, via spliceosome Any process that activates or increases the rate or extent of mRNA splicing via a spliceosomal mechanism.
positive regulation of phosphorylation of RNA polymerase II C-terminal domain Any process that activates or increases the frequency, rate or extent of phosphorylation of RNA polymerase II C-terminal domain.
positive regulation of RNA binding Any process that activates or increases the frequency, rate or extent of RNA binding.
positive regulation of transcription elongation by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
pre-mRNA cleavage required for polyadenylation The targeted, endonucleolytic cleavage of a pre-mRNA, required for polyadenylation of the 3' end. This cleavage is directed by binding sites near the 3' end of the mRNA and leaves a 3' hydoxyl end which then becomes a target for adenylation.
primary miRNA processing A process involved in the conversion of a primary microRNA transcript into a pre-microRNA molecule.
regulation of mRNA processing Any process that modulates the frequency, rate or extent of mRNA processing, those processes involved in the conversion of a primary mRNA transcript into a mature mRNA prior to its translation into polypeptide.
regulation of translational initiation Any process that modulates the frequency, rate or extent of translational initiation.
RNA catabolic process The chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.
snRNA export from nucleus The directed movement of snRNA from the nucleus to the cytoplasm.
spliceosomal complex assembly The aggregation, arrangement and bonding together of a spliceosomal complex, a ribonucleoprotein apparatus that catalyzes nuclear mRNA splicing via transesterification reactions.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5ZJZ6 NCBP1 Nuclear cap-binding protein subunit 1 Gallus gallus (Chicken) PR
Q7K4N3 Cbp80 Nuclear cap-binding protein subunit 1 Drosophila melanogaster (Fruit fly) PR
Q3UYV9 Ncbp1 Nuclear cap-binding protein subunit 1 Mus musculus (Mouse) PR
Q56A27 Ncbp1 Nuclear cap-binding protein subunit 1 Rattus norvegicus (Rat) PR
Q9SIU2 ABH1 Nuclear cap-binding protein subunit 1 Arabidopsis thaliana (Mouse-ear cress) PR
Q6DIE2 ncbp1 Nuclear cap-binding protein subunit 1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MSRRRHSDEN DGGQPHKRRK TSDANETEDH LESLICKVGE KSACSLESNL EGLAGVLEAD
70 80 90 100 110 120
LPNYKSKILR LLCTVARLLP EKLTIYTTLV GLLNARNYNF GGEFVEAMIR QLKESLKANN
130 140 150 160 170 180
YNEAVYLVRF LSDLVNCHVI AAPSMVAMFE NFVSVTQEED VPQVRRDWYV YAFLSSLPWV
190 200 210 220 230 240
GKELYEKKDA EMDRIFANTE SYLKRRQKTH VPMLQVWTAD KPHPQEEYLD CLWAQIQKLK
250 260 270 280 290 300
KDRWQERHIL RPYLAFDSIL CEALQHNLPP FTPPPHTEDS VYPMPRVIFR MFDYTDDPEG
310 320 330 340 350 360
PVMPGSHSVE RFVIEENLHC IIKSHWKERK TCAAQLVSYP GKNKIPLNYH IVEVIFAELF
370 380 390 400 410 420
QLPAPPHIDV MYTTLLIELC KLQPGSLPQV LAQATEMLYM RLDTMNTTCV DRFINWFSHH
430 440 450 460 470 480
LSNFQFRWSW EDWSDCLSQD PESPKPKFVR EVLEKCMRLS YHQRILDIVP PTFSALCPAN
490 500 510 520 530 540
PTCIYKYGDE SSNSLPGHSV ALCLAVAFKS KATNDEIFSI LKDVPNPNQD DDDDEGFSFN
550 560 570 580 590 600
PLKIEVFVQT LLHLAAKSFS HSFSALAKFH EVFKTLAESD EGKLHVLRVM FEVWRNHPQM
610 620 630 640 650 660
IAVLVDKMIR TQIVDCAAVA NWIFSSELSR DFTRLFVWEI LHSTIRKMNK HVLKIQKELE
670 680 690 700 710 720
EAKEKLARQH KRRSDDDDRS SDRKDGVLEE QIERLQEKVE SAQSEQKNLF LVIFQRFIMI
730 740 750 760 770 780
LTEHLVRCET DGTSVLTPWY KNCIERLQQI FLQHHQIIQQ YMVTLENLLF TAELDPHILA
VFQQFCALQA